|
Dr. Edward LeCluyse leads CellzDirect research in the in vitro hepatic area. He also contributes significantly to hepatic cell product and assay development and CellzDirect collaborations, consulting, and scientific lectures. Dr. LeCluyse oversees training of all cell culture staff members, as well as the writing and implementation of the company’s standard operating procedures. Dr. LeCluyse completed his postdoctoral fellowship in Toxicology/Pharmacology at the University of Kansas Medical School under Dr. Andrew Parkinson. He served as senior research biologist at Merck & Co, Inc. and as associate professor at the University of North Carolina-Chapel Hill School of Pharmacy from 1996 until 2004. | 